Study of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants of Any Age With Acute Myeloid Leukemia
Clinical trial NCT04813263 · COMPLETED
Trial details
- NCT number
- NCT04813263
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-05-28
- Primary completion
- 2024-04-30
- Enrollment
- 424
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.